We also treated CLL cells with dinaciclib as a control and observed rapid loss of phosphorylation of RNAP at S2 accompanied by decreased expression of MCL1 (Fig 2B). The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.